Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -157.32% is 77% above its 5-year average of -681.76%, near the high end of its 5-year range (-132680.95%–-22.72%).
72.68% above its 12-month average of -575.86%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -153.32%.
NET PROFIT MARGIN
-157.32%
NET PROFIT MARGIN AVG TTM
-575.86%
NET PROFIT MARGIN AVG 3Y
-693.18%
NET PROFIT MARGIN AVG 5Y
-681.76%
NET PROFIT MARGIN AVG 10Y
-707.65%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+72.68%
CURRENT VS 3Y AVG
+77.30%
CURRENT VS 5Y AVG
+76.92%
CURRENT VS 10Y AVG
+77.77%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Editas Medicine, Inc.
Market Cap
$436.60M
Net Profit Margin
-157.32%
TTM Avg
-575.86%
3Y Avg
-693.18%
5Y Avg
-681.76%
Market Cap
$440.21M
Net Profit Margin
-0.06%
TTM Avg
-74.67%
3Y Avg
-251.03%
5Y Avg
-526.51%
Market Cap
$440.25M
Net Profit Margin
0.00%
TTM Avg
-90.86%
3Y Avg
-351.90%
5Y Avg
-2330.90%
Market Cap
$431.80M
Net Profit Margin
-6.77%
TTM Avg
-13.38%
3Y Avg
-17.48%
5Y Avg
-11.79%
Market Cap
$446.97M
Net Profit Margin
-19.34%
TTM Avg
-27.72%
3Y Avg
-52.31%
5Y Avg
-58.02%
Market Cap
$448.87M
Net Profit Margin
-2178.90%
TTM Avg
-2455.14%
3Y Avg
-5466.68%
5Y Avg
-3741.67%
Market Cap
$450.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$422.12M
Net Profit Margin
-225.34%
TTM Avg
-272.94%
3Y Avg
12.89%
5Y Avg
-949.96%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $436.60M | -157.32% | -575.86% | -693.18% | -681.76% |
| Assembly Biosciences, Inc. (ASMB)vs › | $440.21M | -0.06% | -74.67% | -251.03% | -526.51% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $440.25M | 0.00% | -90.86% | -351.90% | -2330.90% |
| NeoGenomics, Inc. (NEO)vs › | $431.80M | -6.77% | -13.38% | -17.48% | -11.79% |
| NeuroPace, Inc. (NPCE)vs › | $446.97M | -19.34% | -27.72% | -52.31% | -58.02% |
| Rezolute, Inc. (RZLT)vs › | $424.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ovid Therapeutics Inc. (OVID)vs › | $448.87M | -2178.90% | -2455.14% | -5466.68% | -3741.67% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $450.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Senseonics Holdings, Inc. (SENS)vs › | $422.12M | -225.34% | -272.94% | 12.89% | -949.96% |
| Prothena Corporation plc (PRTA)vs › | $420.45M | -80.67% | -1305.53% | -747.23% | -2664.22% |
Operating Margin
-245.2%
Net Profit Margin
-157.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -153.32% |
| 2026-03-31 | -882.44% |
| 2025-12-31 | -22.72% |
| 2025-09-30 | -332.98% |
| 2025-06-30 | -1487.84% |
| 2025-03-31 | -1633.49% |
| 2024-12-31 | -148.33% |
| 2024-09-30 | -101870.49% |
| 2024-06-30 | -13178.75% |
| 2024-03-31 | -5458.15% |
| 2023-12-31 | -31.43% |
| 2023-09-30 | -843.68% |
| 2023-06-30 | -1395.57% |
| 2023-03-31 | -497.78% |
| 2022-12-31 | -929.28% |
| 2022-09-30 | -132680.95% |
| 2022-06-30 | -840.19% |
| 2022-03-31 | -746.05% |
| 2021-12-31 | -332.31% |
| 2021-09-30 | -630.66% |
| 2021-06-30 | -14579.42% |
| 2021-03-31 | -872.87% |
| 2020-12-31 | -547.32% |
| 2020-09-30 | 12.44% |
| 2020-06-30 | -219.29% |
| 2020-03-31 | -659.16% |
| 2019-12-31 | -307.47% |
| 2019-09-30 | -856.06% |
| 2019-06-30 | -1450.04% |
| 2019-03-31 | -1413.68% |
| 2018-12-31 | -409.45% |
| 2018-09-30 | -104.95% |
| 2018-06-30 | -525.27% |
| 2018-03-31 | -787.85% |
| 2017-12-31 | -986.88% |
| 2017-09-30 | -423.42% |
| 2017-06-30 | -853.70% |
| 2017-03-31 | -4559.68% |
| 2016-12-31 | -4384.86% |
| 2016-09-30 | -2185.03% |
| 2016-06-30 | -562.04% |
| 2016-03-31 | -2204.35% |
| 2015-12-31 | -1595.08% |
| 2015-09-30 | -1105.22% |
| 2015-06-30 | -28485.63% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
